New Jersey A4852 allows telemedicine and telehealth for prescribing Schedule II controlled substances without in-person examination or review.
New Jersey A4852 revises requirements for prescribing Schedule II controlled dangerous substances via telemedicine and telehealth. It eliminates the need for an in-person examination or review when a health care provider uses interactive, real-time, two-way audio and video technologies. The bill mandates that health care providers maintain records of patient care and comply with all applicable state and federal statutes and regulations.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
Analyze for Free
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.